ALLOS THERAPEUTICS INC Selling, General and Administrative Expense
ALLOS THERAPEUTICS INC reported Selling, General and Administrative Expense of $14.58 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2012-08-03
- ALLOS THERAPEUTICS INC selling, general and administrative expense for the quarter ending 2012-06-30 was $14.58M, a 27.66% decline year-over-year.
- ALLOS THERAPEUTICS INC selling, general and administrative expense for the quarter ending 2012-03-31 was $15.43M, a 12.07% decline year-over-year.
- ALLOS THERAPEUTICS INC selling, general and administrative expense for the quarter ending 2011-12-31 was $11.42M, a 47.21% decline year-over-year.
- ALLOS THERAPEUTICS INC selling, general and administrative expense for the quarter ending 2011-09-30 was $18.69M, a 0.07% decline year-over-year.
- ALLOS THERAPEUTICS INC selling, general and administrative expense for fiscal 2011 was $67.82M, a 13.92% decline from fiscal 2010.
- ALLOS THERAPEUTICS INC selling, general and administrative expense for fiscal 2010 was $78.78M, a 77.25% increase from fiscal 2009.
- ALLOS THERAPEUTICS INC selling, general and administrative expense for fiscal 2009 was $44.45M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2012-06-30 | $14.58M 10-Q · filed 2012-08-03 | $30.02M 10-Q · filed 2012-08-03 | $41.44M derived: sum of 3 quarters · filed 2012-08-03 | $60.12M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $15.43M 10-Q · filed 2012-05-03 | $26.85M derived: sum of 2 quarters · filed 2012-05-03 | $45.54M derived: sum of 3 quarters · filed 2012-05-03 | $65.70M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | $11.42M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | $30.11M derived: sum of 2 quarters · filed 2012-03-26 | $50.27M derived: sum of 3 quarters · filed 2012-08-03 | $67.82M 10-K · filed 2012-03-26 |
| 2011-09-30 | $18.69M 10-Q/A · filed 2012-03-26 | $38.85M derived: sum of 2 quarters · filed 2012-08-03 | $56.40M 10-Q/A · filed 2012-03-26 | $78.03M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | $20.16M 10-Q · filed 2012-08-03 | $37.71M 10-Q · filed 2012-08-03 | $59.34M derived: sum of 3 quarters · filed 2012-08-03 | $78.04M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $17.55M 10-Q · filed 2012-05-03 | $39.18M derived: sum of 2 quarters · filed 2012-05-03 | $57.88M derived: sum of 3 quarters · filed 2012-05-03 | $78.40M derived: sum of 4 quarters · filed 2012-05-03 |
| 2010-12-31 | $21.63M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | $40.33M derived: sum of 2 quarters · filed 2012-03-26 | $60.85M derived: sum of 3 quarters · filed 2012-03-26 | $78.78M 10-K · filed 2012-03-26 |
| 2010-09-30 | $18.70M 10-Q/A · filed 2012-03-26 | $39.22M derived: sum of 2 quarters · filed 2012-03-26 | $57.15M 10-Q/A · filed 2012-03-26 | |
| 2010-06-30 | $20.52M 10-Q/A · filed 2012-03-26 | $38.45M 10-Q/A · filed 2012-03-26 | ||
| 2009-12-31 | $44.45M 10-K · filed 2012-03-26 |